30.07.2013
- Pfizer, in what could be the prelude to spinning off its generics drug business, said it plans to separate its commercial operations into two units, mainly for patent-protected...
24.07.2013
- Pioneering the Worldwide Health-Care Market - After years of showing low productivity, research and development in leading pharmaceutical and biotech companies is starting to...
22.07.2013
- Vivus has agreed to give dissident shareholder First Manhattan a board majority, ending an acrimonious proxy fight and bringing in a new CEO to the drugmaker accused of bungling...
18.07.2013
- The U.S. Supreme Court ruled on Monday that an Indiana farmer violated agribusiness company Monsanto's patent for a type of soybean. In a case closely watched by the biotechnology...
18.07.2013
- Monsanto said on Wednesday it will withdraw all pending approval requests to grow new types of genetically modified crops in the European Union, due to the lack of commercial...
18.07.2013
- Obesity drug maker Vivus, embroiled in a bitter proxy war with its top shareholder First Manhattan, said on Wednesday that FMC had rejected an offer to give the sides equal...
15.07.2013
- Buying Alexion Pharmaceuticals would help Roche make a splash in the newly lucrative area of rare or so-called orphan diseases, but it could command a price that the Swiss...
11.07.2013
- As activist investors launch more high profile corporate battles in the United States, in Europe they are eschewing public hectoring for private talks. Aggressive activism has had...
10.07.2013
- GlaxoSmithKline plans to exploit new technology from private British biotech company Immunocore to develop next-generation drugs against cancer that fight tumors in ways antibody...
03.07.2013
- Turkish generic drug maker Sanovel has been put up for sale by parent Toksoz Holding and could fetch between $500 million and $1 billion, three sources close to the matter told...
